Back to results
US 2023/0406915 A1Published application
Anti-dkk2 antibody, composition containing anti-dkk2 antibody, and use thereof
AssigneeHjb (Hangzhou) Co., Ltd.)
InventorsDayou Liu, Christopher Hwang
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a humanized and CMC properties-improved anti-DKK2 antibody, a composition containing the antibody, and a method for treating diseases using the antibody or the composition.
Claims11
An antibody specifically binding to a human DKK2 protein, wherein the antibody comprises a heavy chain variable region comprising complementarity-determining regions CDRH1, CDRH2, and CDRH3, and a light chain variable region comprising complementarity-determining regions CDRL1, CDRL2, and CDRL3, wherein:
- (a) CDRH1 has an amino acid sequence as shown in SEQ ID NO:
- 1;
- (b) CDRH2 has an amino acid sequence as shown in SEQ ID NO:
- 2 or SEQ ID NO:
- 3;
- (c) CDRH3 has an amino acid sequence as shown in SEQ ID NO:
- 4;
- (d) CDRL1 has an amino acid sequence as shown in SEQ ID NO:
- 5;
- (e) CDRL2 has an amino acid sequence as shown in SEQ ID NO:
- 6;
- and
- (f) CDRL3 has an amino acid sequence as shown in SEQ ID NO:
- 7.
11 more elements
Dependencies are inferred from the claim text.